Home
Venrock Healthcare Capital Partners EG, 10% Owner: KalVista Pharmaceuticals KALV Buy · Filed 24/02/01
Trade details
- Type
- Insider buy
- Amount
- $1,274,792.53
- Shares · price
- 88,099 sh · $14.47 a share
- Held after
- 4,738,683 sh
- Trade date
- 24/01/30
- Filed
- 24/02/01
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 7 insiders
- Holding change
- +1.9%
KalVista Pharmaceuticals trades, last 26 weeks
What else happened in KalVista Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/12/31~24/02/29Venrock Healthcare Capital Partners EG's recent trades
- Venrock Healthcare Capital Partners EG
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$3M
174,485 sh
$3M
Filed 03/27
Traded 03/25
- Venrock Healthcare Capital Partners EG
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$379.8K
21,386 sh
$379.8K
Filed 03/27
Traded 03/26
- Venrock Healthcare Capital Partners EG
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$290.1K
15,417 sh
$290.1K
Filed 03/27
Traded 03/26
- Venrock Healthcare Capital Partners EG
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$60.9K
3,183 sh
$60.9K
Filed 03/27
Traded 03/26
- Venrock Healthcare Capital Partners EG
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$2,805
160 sh
$2,805
Filed 03/27
Traded 03/25